A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
Clinical trial NCT01461928 · COMPLETED
Trial details
- NCT number
- NCT01461928
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-20
- Primary completion
- 2018-06-02
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.